Clinical Trial Update: The Effects of Prednisone on HIV Levels and the Immune System [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial sponsored by NIAID evaluated prednisone for its effects on HIV viral levels and immune system parameters. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• PREDNISONE (Prednisone)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 2 | Status: COMPLETED